Clopidogrel Teva Pharma (clopidogrel)
- Region
- 🇪🇺 EU
- Active substance
- clopidogrel
- Company
- Teva Pharma B.V.
- Status
- Application withdrawn
- Therapeutic area
- Ischemic Attack, Transient; Peripheral Vascular Diseases; Myocardial Infarction; Acute Coronary Syndrome
- Application
- EMEA/H/C/001052
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 DuoPlavin Authorised · Sanofi Winthrop Industrie
- 🇪🇺 Clopidogrel Zentiva (previously Clopidogrel Winthrop) Authorised · Zentiva k.s.
- 🇪🇺 Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Authorised · Viatris Limited
- 🇪🇺 Iscover Authorised · Sanofi Winthrop Industrie
- 🇪🇺 Plavix Authorised · Sanofi Winthrop Industrie
- 🇪🇺 Grepid Authorised · Pharmathen S.A.
- 🇪🇺 Clopidogrel Krka Authorised · KRKA tovarna zdravil d.d. Novo mesto
- 🇪🇺 Clopidogrel Krka d.d. (previously Zopya) Authorised · Norpharm Regulatory Services Ltd
- 🇪🇺 Clopidogrel TAD Authorised · Tad Pharma GmbH
- 🇪🇺 Zyllt Authorised · KRKA tovarna zdravil d.d. Novo mesto
- 🇪🇺 Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan) Authorised · Mylan Pharmaceuticals Limited
- 🇪🇺 Clopidogrel ratiopharm Authorised · Teva B.V.
Follow Clopidogrel Teva Pharma
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.